Used in pharmaceutical research as a key intermediate in the development of kinase inhibitors, particularly targeting enzymes involved in inflammatory and oncological pathways. Its structural features enable selective binding to specific protein targets, making it valuable in the design of potential anticancer and anti-inflammatory agents. Commonly employed in structure-activity relationship (SAR) studies to optimize potency and selectivity in drug candidates. Also utilized in radiolabeled forms for tracer studies in preclinical models to evaluate biodistribution and target engagement.